KRAS and myeloid leukemia: In addition, results obtained in a mouse model of Kras-induced myeloid leukemia showed that Kras+ NOX2-deficient myeloid cells (Nox2−/−M-KrasG12D) expanded slower than their NOX2-sufficient counterparts.